Catalyst Wire Dossier Catalyst Wire Dossier

MSLN CAR-T

mesothelin-targeted CAR-T
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSLN CAR-T, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors [Phase 1, Phase 2]

See pricing